Musculoskeletal Disorders Pipeline Database 2017

Osteoarthritis, Osteoporosis, Rheumatoid Arthritis, Systemic lupus erythematosus, and Ankylosing Spondylitis - Research and Markets

DUBLIN, Jan 23, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Musculoskeletal Disorders Pipeline Database - 2017" drug pipelines to their offering.

Musculoskeletal Disorders Pipeline Highlights Database - 2017, provides most up-to-date information on key pipeline products in the global Musculoskeletal Disorders market.

It covers emerging therapies for Musculoskeletal Disorders in active clinical development stages including early and late stage clinical trials.

Key indications covered in this database include Osteoarthritis, Osteoporosis, Rheumatoid Arthritis, Systemic lupus erythematosus, and Ankylosing Spondylitis. The pipeline data is presented in an excel dashboard with filtering options.

The pipeline data presented in this database helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

By Indication: The database presents pipeline by Musculoskeletal indications. Key indications covered in this database include Osteoarthritis, Osteoporosis, Rheumatoid Arthritis, Systemic lupus erythematosus, and Ankylosing Spondylitis.

By Clinical Trial Stages:

The database provides Musculoskeletal Disorders pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

By Drug Mechanism Classes: The database provides Musculoskeletal Disorders pipeline products by their dominant drug mechanism class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

By Company:

The database provides Musculoskeletal Disorders pipeline products by the company.

Summary: - Musculoskeletal Disorders Pipeline by Indication

- Musculoskeletal Disorders Pipeline by Clinical Trial Phase

- Musculoskeletal Disorders Pipeline by Drug Mechanism Classes

- Musculoskeletal Disorders Pipeline by Company

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/p74lxd/musculoskeletal

Media Contact:

Research and Markets

Laura Wood, Senior Manager

[e-mail]

For E.S.T Office Hours Call [phone]

For U.S./CAN Toll Free Call [phone]

For GMT Office Hours Call [phone]

U.S. Fax: [phone]

Fax (outside U.S.): [phone]